Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Myelos Neurosciences

1994 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$35M LATEST DEAL AMOUNT
Description

Developer of therapeutics for neuropathic pain, peripheral neuropathy and neurodegenerative central nervous system disorders. The company provides peptide therapy to treat nervous system disorders and related degenerative diseases to treat pain syndromes and peripheral neuropathies.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
  • 4940 Carroll Canyon Road
  • Suite M
  • San Diego, CA 92121
  • United States

+1 (619) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Myelos Neurosciences’s full profile, request a free trial.

Myelos Neurosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 19-Mar-2001 $35M 0000 Completed
1. Early Stage VC Completed
To view this company’s complete deal history including valuation and funding, request access »

Myelos Neurosciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Yellowstone Capital Partners PE/Buyout Minority 000 0000 000000 0

Myelos Neurosciences Executive Team (2)

Name Title Board
Seat
Contact
Info
John O'Brien Founder

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »